发明名称 Modulation of excitable tissue function by peripherally administered erythropoietin
摘要 Disclosed is a pharmaceutical composition packaged in a single dose vial adapted for modulation of excitable tissue, enhancement of cognitive function or delivery of compounds across the endothelial tight junctions which comprises, per dosage unit, an effective non-toxic amount within the range from about 150,000 to 500,000 Units of EPO, an EPO receptor activity modulator, an EPO-activated receptor modulator which are capable of activating EPR receptors of excitable tissue.
申请公布号 NZ545478(A) 申请公布日期 2008.04.30
申请号 NZ20000545478 申请日期 2000.04.13
申请人 THE KENNETH S. WARREN INSTITUTE, INC. 发明人 BRINES, MICHAEL;CERAMI, ANTHONY;CERAMI, CARLA
分类号 A61K45/06;A61K38/00;A61K38/18;A61K38/22;A61P9/00;A61P9/02;A61P9/10;A61P25/16;A61P25/22;A61P25/28;A61P25/32;A61P27/02;A61P27/06;A61P29/00;A61P43/00;C07K14/00;(IPC1-7):A61K38/19;A61P25/00;A61P7/00;C07K14/505 主分类号 A61K45/06
代理机构 代理人
主权项
地址